Skip to main content

Table 1 Output of metrics describing characteristics of websites for regenerative medicine clinics in Tijuana and San Diego

From: Online marketing practices of regenerative medicine clinics in US-Mexico border region: a web surveillance study

Category

Characteristic

San Diego metrics

Tijuana metrics

Online Communication and Partnership Profile

Facebook presence

76.9%

65.5%

Twitter presence

43.5%

26.4%

Other online presence

63.9%

37.3%

Address provided

97.3%

88.2%

Phone number provided

99.3%

97.3%

Email provided

63.9%

68.2%

Contact form

95.9%

85.5%

Multiple clinics in area

27.9%

6.4%

Partners mentioned

2.0%

12.7%

Links to suppliers or other clinics

3.4%

10.9%

Language: English

95.2%

40.0%

Language: Spanish

0.0%

40.0%

Language: Both English and Spanish

4.8%

20.0%

Partner location: Mexico

0.0%

78.6%

Partner location: USA

100%

0.0%

Partner location: Mexico and USA

0.0%

1.0%

Partner location: Other

0.0%

2.0%

Claims to Scientific Legitimacy

Affiliation with academia

7.5%

0.9%

Affiliation with hospital/medical center

12.9%

13.6%

Affiliation with society/network

27.9%

13.6%

Affiliation with other authority

2.0%

6.4%

Clinical trials conducted

5.4%

5.5%

License for regenerative medicine

0.0%

11.8%

Accreditation from professional org.

25.9%

20.9%

FDA Approval

7.5%

1.8%

COFEPRIS Approval

0.0%

12.7%

Patent pending

0.0%

0.0%

Patent approved

0.7%

0.9%

Evidence cited: any (including testimonials)

39.5%

33.6%

Evidence cited: peer-reviewed

9.5%

5.5%

Evidence cited: lay press/blogs

4.8%

3.6%

Evidence cited: self-publication

17.7%

6.4%

Intervention Details

Number of diseases treated (mean)

6.04

8.15

Cost per Session

$1523.04

$3691

PRP Offered

87.1%

67.3%

Follow-up Mentioned

6.1%

11.8%

Expectation: Unclear

17%

49.1%

Expectation: Improvement

76.9%

48.2%

Expectation: Cure

0.7%

0.0%

Risk: Not mentioned

41.5%

55.5%

Risk: Safe

51.0%

38.2%

Risk: Minor

5.4%

6.0%

Risk: Moderate

2.0%

0.0%

Risk: Major

0.0%

0.0%

Tissue origin: USA

84.4%

0.9%

Tissue origin: Mexico

0.0%

60.0%

Tissue origin: Unspecified

15.6%

39.1%

Tissue source: Autologous

84.4%

61.8%

Tissue source: Allogenic

13.6%

20.0%

Tissue source: Xenogenic

1.4%

1.8%

Tissue source: Unspecified

10.9%

32.7%

Cell type: Adult Stem Cells

21.8/%

29.1%

Cell type: Embryonic Stem Cells

0.0%

3.6%

Cell type: IPSC

0.0%

0.0%

Cell type: Cord, amniotic, or placental

13.6%

8.2%

Cell type: Unspecified

11.6%

26.4%

Route: Intrathecal

0.7%

8.2%

Route: Oral

0.0%

0.0%

Route: Topical

0.7%

0.9%

Route: Intravenous

6.8%

14.5%

Route: Intramuscular

0.7%

4.5%

Route: Other

82.3%

50.9%

Route: Unspecified

13.6%

42.7%